Creatine for women: what it does, how much to take, and how safe it is

What is creatine, and why do women take it?

Your body makes creatine on its own and keeps a store of it. A 2021 review of creatine across women's lives estimates that women's natural stores are 70–80% lower than men's, while noting that the data behind that estimate are limited.

Research now looks at women in their own right. That 2021 review took a lifespan view, and a 2025 review followed the evidence from menstruation through pregnancy to menopause.

Creatine monohydrate is the form named in the International Society of Sports Nutrition (ISSN) position stand, and every dose given here refers to it. No study in this evidence points to a particular product, so the best creatine for women is, on the evidence, plain monohydrate.

The reason most women take a creatine supplement is practical. It supports strength training, and the benefits in the research are described with training in place, so it works alongside lifting, not instead of it.

What does the evidence show about creatine for women?

The most dependable finding is also the simplest. Paired with lifting, creatine monohydrate improves strength and lean mass. That is the conclusion of the ISSN position stand (2017), and it is the basis for the guidance at each adult stage, from the reproductive years to older age. The position stand was funded by a grant from the Council for Responsible Nutrition, which is a good reason to read it alongside the reviews and trials below. These are the creatine benefits women can expect the evidence to back: stronger lifts and a little more muscle, built together with training.

How large the effect is has been measured most carefully in one group. A 2026 meta-analysis pooled 7 randomized trials in postmenopausal women, 608 women in all. Compared with placebo, creatine added about 7.5 kg to leg-press strength and about 0.37 kg of lean mass. Those numbers belong to that stage of life. For younger adult women, the support comes from the position stand's broader conclusion, not from a pooled figure of this kind.

Safety is a normal thing to ask about with anything taken every day, and kidneys come up often. The ISSN position stand found no compelling evidence that creatine harms kidney function in healthy or clinical populations. The 2021 review, citing a systematic review of safety in women, reported a lack of adverse effects on the gastrointestinal, renal, hepatic or cardiovascular systems. That is an encouraging record, not a guarantee: it rests on a small number of reviews, and it does not stand in for a doctor's advice for anyone with kidney disease.

The evidence is not equally deep at every stage. Perimenopause is the most thinly studied, because few studies enroll perimenopausal women specifically and they are usually grouped with postmenopausal women (2025 review). The dose guidance for perimenopause is the same as for the stages around it, and it rests on that wider body of work.

How much creatine do women take, and how often?

A sensible target is 3–5 g of creatine monohydrate a day, taken as a steady daily habit. That is the range given for each adult stage in the life-stage table, which also carries the line for under-18s. One finding sits at its upper edge: in the postmenopausal trials, the clearest lean mass gains came at 5 g a day or more, combined with resistance training. That result belongs to postmenopausal women who were also training, and the evidence here does not extend it to other stages.

The dose is only half of the picture. The gains in the research come with lifting, so regular strength training for women is what gives creatine something to work with. Many women find it easiest to tie the daily amount to something they already do, such as breakfast or a drink after the gym.

Two situations are worth a conversation before starting. In pregnancy, the 2021 review describes the evidence as limited, so there is no evidence-based dose to offer, and your doctor or midwife is the person to ask. With kidney disease, the guidance is to check with your doctor, or your GP in the UK, first.

What did the studies do, and what did they leave open?

The sources behind these findings are of different kinds. The position stand and the two reviews are summaries of earlier research, weighed by their authors. The 2026 meta-analysis works differently: it combines randomized trials, each comparing creatine with a placebo, into a single pooled result.

A pooled result is only as broad as the women in it. Those trials enrolled postmenopausal women, and the lean mass finding was clearest when creatine was combined with resistance training, so it says little about creatine taken without training or about earlier stages of life.

Bone is the clearest open question. The same meta-analysis found the effect on bone mineral density unclear, with individual trials pointing in different directions. For perimenopause and menopause, bone and brain are both described as early research, so it's worth holding them as possibilities, not promises.

Trial results are also averages. They describe groups of women, not any one woman, so how your own training feels over time is part of the picture too.

Next steps

A good place to start is your own week. If lifting is already in it, 3–5 g of creatine monohydrate a day is the amount the evidence supports; if not, the training comes first and the supplement can follow. From there, find your stage in the life-stage table, and if you are pregnant, have kidney disease or take regular medicines, bring the question to your doctor (your GP in the UK) or a pharmacist first. This is not one size fits all, so what fits your body, your training and your budget is yours to decide.